nodes	percent_of_prediction	percent_of_DWPC	metapath
Repaglinide—CYP2C8—Spironolactone—dilated cardiomyopathy	0.298	0.531	CbGbCtD
Repaglinide—ALB—Furosemide—dilated cardiomyopathy	0.263	0.469	CbGbCtD
Repaglinide—ABCC8—ATP sensitive Potassium channels—ABCC9—dilated cardiomyopathy	0.0431	0.211	CbGpPWpGaD
Repaglinide—KCNJ11—ATP sensitive Potassium channels—ABCC9—dilated cardiomyopathy	0.0418	0.205	CbGpPWpGaD
Repaglinide—Vasculitis—Spironolactone—dilated cardiomyopathy	0.0107	0.0457	CcSEcCtD
Repaglinide—ABCC8—Inwardly rectifying K+ channels—ABCC9—dilated cardiomyopathy	0.00838	0.041	CbGpPWpGaD
Repaglinide—KCNJ11—Inwardly rectifying K+ channels—ABCC9—dilated cardiomyopathy	0.00812	0.0398	CbGpPWpGaD
Repaglinide—ABCC8—ABC-family proteins mediated transport—ABCC9—dilated cardiomyopathy	0.00743	0.0364	CbGpPWpGaD
Repaglinide—Vasculitis—Furosemide—dilated cardiomyopathy	0.00582	0.0248	CcSEcCtD
Repaglinide—Stevens-Johnson syndrome—Spironolactone—dilated cardiomyopathy	0.0058	0.0247	CcSEcCtD
Repaglinide—Erythema multiforme—Spironolactone—dilated cardiomyopathy	0.00496	0.0212	CcSEcCtD
Repaglinide—Alopecia—Spironolactone—dilated cardiomyopathy	0.00464	0.0198	CcSEcCtD
Repaglinide—Haemolytic anaemia—Furosemide—dilated cardiomyopathy	0.00457	0.0195	CcSEcCtD
Repaglinide—Vasculitis—Lisinopril—dilated cardiomyopathy	0.00437	0.0186	CcSEcCtD
Repaglinide—PPARG—Nuclear Receptor transcription pathway—NR3C2—dilated cardiomyopathy	0.00434	0.0212	CbGpPWpGaD
Repaglinide—Anaphylactoid reaction—Furosemide—dilated cardiomyopathy	0.00426	0.0182	CcSEcCtD
Repaglinide—Leukopenia—Spironolactone—dilated cardiomyopathy	0.00409	0.0174	CcSEcCtD
Repaglinide—Anaphylactic shock—Spironolactone—dilated cardiomyopathy	0.00373	0.0159	CcSEcCtD
Repaglinide—Thrombocytopenia—Spironolactone—dilated cardiomyopathy	0.00365	0.0156	CcSEcCtD
Repaglinide—Hepatic function abnormal—Lisinopril—dilated cardiomyopathy	0.00354	0.0151	CcSEcCtD
Repaglinide—Pancreatitis—Furosemide—dilated cardiomyopathy	0.0035	0.0149	CcSEcCtD
Repaglinide—Haemolytic anaemia—Lisinopril—dilated cardiomyopathy	0.00343	0.0146	CcSEcCtD
Repaglinide—PPARG—PPARA activates gene expression—ANKRD1—dilated cardiomyopathy	0.00338	0.0166	CbGpPWpGaD
Repaglinide—PPARG—Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)—ANKRD1—dilated cardiomyopathy	0.00331	0.0162	CbGpPWpGaD
Repaglinide—ABCC8—Potassium Channels—ABCC9—dilated cardiomyopathy	0.00331	0.0162	CbGpPWpGaD
Repaglinide—Gastrointestinal disorder—Spironolactone—dilated cardiomyopathy	0.00322	0.0137	CcSEcCtD
Repaglinide—Hyperglycaemia—Furosemide—dilated cardiomyopathy	0.00322	0.0137	CcSEcCtD
Repaglinide—KCNJ11—Potassium Channels—ABCC9—dilated cardiomyopathy	0.00321	0.0157	CbGpPWpGaD
Repaglinide—Anaphylactoid reaction—Lisinopril—dilated cardiomyopathy	0.0032	0.0136	CcSEcCtD
Repaglinide—Hypoglycaemia—Lisinopril—dilated cardiomyopathy	0.00317	0.0135	CcSEcCtD
Repaglinide—Stevens-Johnson syndrome—Furosemide—dilated cardiomyopathy	0.00315	0.0134	CcSEcCtD
Repaglinide—Hepatobiliary disease—Furosemide—dilated cardiomyopathy	0.00301	0.0128	CcSEcCtD
Repaglinide—Urticaria—Spironolactone—dilated cardiomyopathy	0.00296	0.0126	CcSEcCtD
Repaglinide—PPARG—Circadian rythm related genes—SIK1—dilated cardiomyopathy	0.00276	0.0135	CbGpPWpGaD
Repaglinide—Visual impairment—Furosemide—dilated cardiomyopathy	0.00275	0.0117	CcSEcCtD
Repaglinide—Hypersensitivity—Spironolactone—dilated cardiomyopathy	0.00275	0.0117	CcSEcCtD
Repaglinide—Erythema multiforme—Furosemide—dilated cardiomyopathy	0.0027	0.0115	CcSEcCtD
Repaglinide—Eye disorder—Furosemide—dilated cardiomyopathy	0.00267	0.0114	CcSEcCtD
Repaglinide—Pruritus—Spironolactone—dilated cardiomyopathy	0.00264	0.0112	CcSEcCtD
Repaglinide—Pancreatitis—Lisinopril—dilated cardiomyopathy	0.00262	0.0112	CcSEcCtD
Repaglinide—Angina pectoris—Lisinopril—dilated cardiomyopathy	0.00261	0.0111	CcSEcCtD
Repaglinide—Immune system disorder—Furosemide—dilated cardiomyopathy	0.00258	0.011	CcSEcCtD
Repaglinide—Bronchitis—Lisinopril—dilated cardiomyopathy	0.00257	0.011	CcSEcCtD
Repaglinide—Diarrhoea—Spironolactone—dilated cardiomyopathy	0.00255	0.0109	CcSEcCtD
Repaglinide—Arrhythmia—Furosemide—dilated cardiomyopathy	0.00255	0.0109	CcSEcCtD
Repaglinide—PPARG—RXR and RAR heterodimerization with other nuclear receptor—RPS6KB1—dilated cardiomyopathy	0.00252	0.0123	CbGpPWpGaD
Repaglinide—Malnutrition—Furosemide—dilated cardiomyopathy	0.00249	0.0106	CcSEcCtD
Repaglinide—Erythema—Furosemide—dilated cardiomyopathy	0.00249	0.0106	CcSEcCtD
Repaglinide—Hyperglycaemia—Lisinopril—dilated cardiomyopathy	0.00241	0.0103	CcSEcCtD
Repaglinide—Vomiting—Spironolactone—dilated cardiomyopathy	0.00237	0.0101	CcSEcCtD
Repaglinide—Stevens-Johnson syndrome—Lisinopril—dilated cardiomyopathy	0.00237	0.0101	CcSEcCtD
Repaglinide—Acute coronary syndrome—Lisinopril—dilated cardiomyopathy	0.00235	0.01	CcSEcCtD
Repaglinide—Rash—Spironolactone—dilated cardiomyopathy	0.00235	0.01	CcSEcCtD
Repaglinide—Dermatitis—Spironolactone—dilated cardiomyopathy	0.00235	0.01	CcSEcCtD
Repaglinide—Myocardial infarction—Lisinopril—dilated cardiomyopathy	0.00234	0.00997	CcSEcCtD
Repaglinide—Headache—Spironolactone—dilated cardiomyopathy	0.00234	0.00996	CcSEcCtD
Repaglinide—Jaundice—Lisinopril—dilated cardiomyopathy	0.00233	0.00992	CcSEcCtD
Repaglinide—Urinary tract infection—Lisinopril—dilated cardiomyopathy	0.00232	0.00989	CcSEcCtD
Repaglinide—PPARG—Fatty acid, triacylglycerol, and ketone body metabolism—ANKRD1—dilated cardiomyopathy	0.00228	0.0112	CbGpPWpGaD
Repaglinide—Hepatobiliary disease—Lisinopril—dilated cardiomyopathy	0.00226	0.00962	CcSEcCtD
Repaglinide—Sinusitis—Lisinopril—dilated cardiomyopathy	0.00224	0.00955	CcSEcCtD
Repaglinide—Leukopenia—Furosemide—dilated cardiomyopathy	0.00222	0.00949	CcSEcCtD
Repaglinide—Nausea—Spironolactone—dilated cardiomyopathy	0.00221	0.00944	CcSEcCtD
Repaglinide—Rhinitis—Lisinopril—dilated cardiomyopathy	0.00215	0.00916	CcSEcCtD
Repaglinide—Hepatitis—Lisinopril—dilated cardiomyopathy	0.00214	0.00913	CcSEcCtD
Repaglinide—Oedema peripheral—Lisinopril—dilated cardiomyopathy	0.00211	0.009	CcSEcCtD
Repaglinide—Unspecified disorder of skin and subcutaneous tissue—Furosemide—dilated cardiomyopathy	0.0021	0.00896	CcSEcCtD
Repaglinide—Anaphylactic shock—Furosemide—dilated cardiomyopathy	0.00203	0.00865	CcSEcCtD
Repaglinide—Erythema multiforme—Lisinopril—dilated cardiomyopathy	0.00203	0.00864	CcSEcCtD
Repaglinide—Thrombocytopenia—Furosemide—dilated cardiomyopathy	0.00199	0.00847	CcSEcCtD
Repaglinide—Skin disorder—Furosemide—dilated cardiomyopathy	0.00197	0.0084	CcSEcCtD
Repaglinide—PPARG—Noncanonical Wnt signaling pathway—RAC1—dilated cardiomyopathy	0.00193	0.00943	CbGpPWpGaD
Repaglinide—Arrhythmia—Lisinopril—dilated cardiomyopathy	0.00191	0.00816	CcSEcCtD
Repaglinide—Alopecia—Lisinopril—dilated cardiomyopathy	0.00189	0.00807	CcSEcCtD
Repaglinide—Malnutrition—Lisinopril—dilated cardiomyopathy	0.00186	0.00795	CcSEcCtD
Repaglinide—Erythema—Lisinopril—dilated cardiomyopathy	0.00186	0.00795	CcSEcCtD
Repaglinide—Paraesthesia—Furosemide—dilated cardiomyopathy	0.00182	0.00777	CcSEcCtD
Repaglinide—Back pain—Lisinopril—dilated cardiomyopathy	0.0018	0.00769	CcSEcCtD
Repaglinide—Gastrointestinal disorder—Furosemide—dilated cardiomyopathy	0.00175	0.00747	CcSEcCtD
Repaglinide—Constipation—Furosemide—dilated cardiomyopathy	0.00173	0.0074	CcSEcCtD
Repaglinide—PPARG—Wnt Signaling Pathway Netpath—GJA1—dilated cardiomyopathy	0.00171	0.00839	CbGpPWpGaD
Repaglinide—Leukopenia—Lisinopril—dilated cardiomyopathy	0.00167	0.00712	CcSEcCtD
Repaglinide—Gastrointestinal pain—Furosemide—dilated cardiomyopathy	0.00166	0.00707	CcSEcCtD
Repaglinide—Palpitations—Lisinopril—dilated cardiomyopathy	0.00165	0.00703	CcSEcCtD
Repaglinide—Urticaria—Furosemide—dilated cardiomyopathy	0.00161	0.00687	CcSEcCtD
Repaglinide—Abdominal pain—Furosemide—dilated cardiomyopathy	0.0016	0.00684	CcSEcCtD
Repaglinide—Chest pain—Lisinopril—dilated cardiomyopathy	0.00159	0.00677	CcSEcCtD
Repaglinide—Arthralgia—Lisinopril—dilated cardiomyopathy	0.00159	0.00677	CcSEcCtD
Repaglinide—Unspecified disorder of skin and subcutaneous tissue—Lisinopril—dilated cardiomyopathy	0.00158	0.00672	CcSEcCtD
Repaglinide—KCNJ11—Type II diabetes mellitus—TNF—dilated cardiomyopathy	0.00152	0.00746	CbGpPWpGaD
Repaglinide—Oedema—Lisinopril—dilated cardiomyopathy	0.00152	0.00649	CcSEcCtD
Repaglinide—Anaphylactic shock—Lisinopril—dilated cardiomyopathy	0.00152	0.00649	CcSEcCtD
Repaglinide—Hypersensitivity—Furosemide—dilated cardiomyopathy	0.00149	0.00637	CcSEcCtD
Repaglinide—Thrombocytopenia—Lisinopril—dilated cardiomyopathy	0.00149	0.00635	CcSEcCtD
Repaglinide—Skin disorder—Lisinopril—dilated cardiomyopathy	0.00148	0.0063	CcSEcCtD
Repaglinide—ABCC8—Neuronal System—ABCC9—dilated cardiomyopathy	0.00144	0.00708	CbGpPWpGaD
Repaglinide—Pruritus—Furosemide—dilated cardiomyopathy	0.00143	0.00612	CcSEcCtD
Repaglinide—PPARG—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—FASLG—dilated cardiomyopathy	0.00143	0.00698	CbGpPWpGaD
Repaglinide—KCNJ11—Neuronal System—ABCC9—dilated cardiomyopathy	0.0014	0.00686	CbGpPWpGaD
Repaglinide—ALB—Platelet degranulation—TTN—dilated cardiomyopathy	0.0014	0.00685	CbGpPWpGaD
Repaglinide—Diarrhoea—Furosemide—dilated cardiomyopathy	0.00139	0.00592	CcSEcCtD
Repaglinide—Musculoskeletal discomfort—Lisinopril—dilated cardiomyopathy	0.00139	0.00591	CcSEcCtD
Repaglinide—ABCC8—Neuronal System—ACTN2—dilated cardiomyopathy	0.00138	0.00678	CbGpPWpGaD
Repaglinide—Paraesthesia—Lisinopril—dilated cardiomyopathy	0.00137	0.00583	CcSEcCtD
Repaglinide—KCNJ11—Neuronal System—ACTN2—dilated cardiomyopathy	0.00134	0.00658	CbGpPWpGaD
Repaglinide—PPARG—Developmental Biology—ZIC3—dilated cardiomyopathy	0.00134	0.00657	CbGpPWpGaD
Repaglinide—Dyspepsia—Lisinopril—dilated cardiomyopathy	0.00134	0.00571	CcSEcCtD
Repaglinide—ALB—Response to elevated platelet cytosolic Ca2+—TTN—dilated cardiomyopathy	0.00133	0.00653	CbGpPWpGaD
Repaglinide—Gastrointestinal disorder—Lisinopril—dilated cardiomyopathy	0.00131	0.0056	CcSEcCtD
Repaglinide—PPARG—Wnt Signaling Pathway Netpath—RAC1—dilated cardiomyopathy	0.00131	0.0064	CbGpPWpGaD
Repaglinide—Constipation—Lisinopril—dilated cardiomyopathy	0.0013	0.00555	CcSEcCtD
Repaglinide—Vomiting—Furosemide—dilated cardiomyopathy	0.00129	0.0055	CcSEcCtD
Repaglinide—Rash—Furosemide—dilated cardiomyopathy	0.00128	0.00545	CcSEcCtD
Repaglinide—Dermatitis—Furosemide—dilated cardiomyopathy	0.00128	0.00545	CcSEcCtD
Repaglinide—Headache—Furosemide—dilated cardiomyopathy	0.00127	0.00542	CcSEcCtD
Repaglinide—Gastrointestinal pain—Lisinopril—dilated cardiomyopathy	0.00124	0.00531	CcSEcCtD
Repaglinide—ALB—Platelet degranulation—ACTN2—dilated cardiomyopathy	0.00121	0.00594	CbGpPWpGaD
Repaglinide—Urticaria—Lisinopril—dilated cardiomyopathy	0.00121	0.00516	CcSEcCtD
Repaglinide—Nausea—Furosemide—dilated cardiomyopathy	0.0012	0.00514	CcSEcCtD
Repaglinide—Abdominal pain—Lisinopril—dilated cardiomyopathy	0.0012	0.00513	CcSEcCtD
Repaglinide—ALB—Response to elevated platelet cytosolic Ca2+—ACTN2—dilated cardiomyopathy	0.00116	0.00566	CbGpPWpGaD
Repaglinide—PPARG—Transcription factor regulation in adipogenesis—TNF—dilated cardiomyopathy	0.00113	0.00551	CbGpPWpGaD
Repaglinide—Hypersensitivity—Lisinopril—dilated cardiomyopathy	0.00112	0.00478	CcSEcCtD
Repaglinide—PPARG—Adipogenesis—LMNA—dilated cardiomyopathy	0.0011	0.00537	CbGpPWpGaD
Repaglinide—Pruritus—Lisinopril—dilated cardiomyopathy	0.00108	0.00459	CcSEcCtD
Repaglinide—Diarrhoea—Lisinopril—dilated cardiomyopathy	0.00104	0.00444	CcSEcCtD
Repaglinide—ALB—Platelet degranulation—VCL—dilated cardiomyopathy	0.00103	0.00505	CbGpPWpGaD
Repaglinide—PPARG—Developmental Biology—SCN5A—dilated cardiomyopathy	0.00102	0.00498	CbGpPWpGaD
Repaglinide—PPARG—Transcriptional regulation of white adipocyte differentiation—CD36—dilated cardiomyopathy	0.00101	0.00496	CbGpPWpGaD
Repaglinide—PPARG—RXR and RAR heterodimerization with other nuclear receptor—TNF—dilated cardiomyopathy	0.000984	0.00482	CbGpPWpGaD
Repaglinide—ALB—Response to elevated platelet cytosolic Ca2+—VCL—dilated cardiomyopathy	0.000983	0.00481	CbGpPWpGaD
Repaglinide—Vomiting—Lisinopril—dilated cardiomyopathy	0.000968	0.00413	CcSEcCtD
Repaglinide—Rash—Lisinopril—dilated cardiomyopathy	0.00096	0.00409	CcSEcCtD
Repaglinide—Dermatitis—Lisinopril—dilated cardiomyopathy	0.000959	0.00409	CcSEcCtD
Repaglinide—Headache—Lisinopril—dilated cardiomyopathy	0.000953	0.00407	CcSEcCtD
Repaglinide—SLCO1B1—SLC-mediated transmembrane transport—SLC22A5—dilated cardiomyopathy	0.000928	0.00454	CbGpPWpGaD
Repaglinide—PPARG—Metabolism of lipids and lipoproteins—ANKRD1—dilated cardiomyopathy	0.000908	0.00445	CbGpPWpGaD
Repaglinide—Nausea—Lisinopril—dilated cardiomyopathy	0.000904	0.00385	CcSEcCtD
Repaglinide—ABCC8—Transmembrane transport of small molecules—RYR2—dilated cardiomyopathy	0.000859	0.00421	CbGpPWpGaD
Repaglinide—PPARG—Metabolism of lipids and lipoproteins—TAZ—dilated cardiomyopathy	0.000854	0.00418	CbGpPWpGaD
Repaglinide—ABCC8—Transmembrane transport of small molecules—PLN—dilated cardiomyopathy	0.000835	0.00409	CbGpPWpGaD
Repaglinide—ABCC8—Transmembrane transport of small molecules—SLC22A5—dilated cardiomyopathy	0.000835	0.00409	CbGpPWpGaD
Repaglinide—ABCC8—Transmembrane transport of small molecules—ABCC9—dilated cardiomyopathy	0.000777	0.0038	CbGpPWpGaD
Repaglinide—PPARG—PPARA activates gene expression—CD36—dilated cardiomyopathy	0.000761	0.00373	CbGpPWpGaD
Repaglinide—ALB—Binding and Uptake of Ligands by Scavenger Receptors—CD36—dilated cardiomyopathy	0.000754	0.00369	CbGpPWpGaD
Repaglinide—PPARG—Generic Transcription Pathway—NR3C2—dilated cardiomyopathy	0.000749	0.00367	CbGpPWpGaD
Repaglinide—PPARG—Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)—CD36—dilated cardiomyopathy	0.000745	0.00365	CbGpPWpGaD
Repaglinide—PPARG—Regulation of retinoblastoma protein—RAF1—dilated cardiomyopathy	0.000715	0.0035	CbGpPWpGaD
Repaglinide—SLCO1B1—Metabolism of lipids and lipoproteins—ANKRD1—dilated cardiomyopathy	0.000715	0.0035	CbGpPWpGaD
Repaglinide—PPARG—PPARA activates gene expression—AGT—dilated cardiomyopathy	0.000685	0.00336	CbGpPWpGaD
Repaglinide—ALB—Vitamin B12 Metabolism—SOD2—dilated cardiomyopathy	0.000681	0.00334	CbGpPWpGaD
Repaglinide—SLCO1B1—Metabolism of lipids and lipoproteins—TAZ—dilated cardiomyopathy	0.000673	0.00329	CbGpPWpGaD
Repaglinide—PPARG—Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)—AGT—dilated cardiomyopathy	0.000671	0.00328	CbGpPWpGaD
Repaglinide—CYP2C8—Arachidonic acid metabolism—GPX1—dilated cardiomyopathy	0.000664	0.00325	CbGpPWpGaD
Repaglinide—PPARG—Adipogenesis—FAS—dilated cardiomyopathy	0.00064	0.00313	CbGpPWpGaD
Repaglinide—ALB—Platelet activation, signaling and aggregation—TTN—dilated cardiomyopathy	0.000621	0.00304	CbGpPWpGaD
Repaglinide—PPARG—Adipogenesis—AGT—dilated cardiomyopathy	0.000599	0.00294	CbGpPWpGaD
Repaglinide—PPARG—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—TNF—dilated cardiomyopathy	0.000583	0.00286	CbGpPWpGaD
Repaglinide—ABCC8—Metabolism—ANKRD1—dilated cardiomyopathy	0.000564	0.00277	CbGpPWpGaD
Repaglinide—ALB—Folate Metabolism—SOD2—dilated cardiomyopathy	0.000554	0.00272	CbGpPWpGaD
Repaglinide—KCNJ11—Metabolism—ANKRD1—dilated cardiomyopathy	0.000547	0.00268	CbGpPWpGaD
Repaglinide—ALB—Platelet activation, signaling and aggregation—ACTN2—dilated cardiomyopathy	0.000538	0.00264	CbGpPWpGaD
Repaglinide—ABCC8—Metabolism—TAZ—dilated cardiomyopathy	0.000531	0.0026	CbGpPWpGaD
Repaglinide—ALB—SLC-mediated transmembrane transport—SLC22A5—dilated cardiomyopathy	0.00053	0.0026	CbGpPWpGaD
Repaglinide—ALB—Folate Metabolism—GPX1—dilated cardiomyopathy	0.000529	0.00259	CbGpPWpGaD
Repaglinide—KCNJ11—Metabolism—TAZ—dilated cardiomyopathy	0.000515	0.00252	CbGpPWpGaD
Repaglinide—PPARG—Fatty acid, triacylglycerol, and ketone body metabolism—CD36—dilated cardiomyopathy	0.000513	0.00251	CbGpPWpGaD
Repaglinide—SLCO1B1—Transmembrane transport of small molecules—RYR2—dilated cardiomyopathy	0.000485	0.00237	CbGpPWpGaD
Repaglinide—ABCC8—Metabolism—SDHA—dilated cardiomyopathy	0.00048	0.00235	CbGpPWpGaD
Repaglinide—SLCO1B1—Transmembrane transport of small molecules—SLC22A5—dilated cardiomyopathy	0.000471	0.00231	CbGpPWpGaD
Repaglinide—SLCO1B1—Transmembrane transport of small molecules—PLN—dilated cardiomyopathy	0.000471	0.00231	CbGpPWpGaD
Repaglinide—PPARG—Generic Transcription Pathway—NPPA—dilated cardiomyopathy	0.00047	0.0023	CbGpPWpGaD
Repaglinide—KCNJ11—Metabolism—SDHA—dilated cardiomyopathy	0.000465	0.00228	CbGpPWpGaD
Repaglinide—PPARG—Fatty acid, triacylglycerol, and ketone body metabolism—AGT—dilated cardiomyopathy	0.000462	0.00226	CbGpPWpGaD
Repaglinide—ALB—Platelet activation, signaling and aggregation—VCL—dilated cardiomyopathy	0.000457	0.00224	CbGpPWpGaD
Repaglinide—PPARG—Circadian rythm related genes—FAS—dilated cardiomyopathy	0.000452	0.00221	CbGpPWpGaD
Repaglinide—PPARG—Signaling events mediated by HDAC Class I—TNF—dilated cardiomyopathy	0.000446	0.00218	CbGpPWpGaD
Repaglinide—ALB—Platelet degranulation—CD36—dilated cardiomyopathy	0.000442	0.00216	CbGpPWpGaD
Repaglinide—ALB—Selenium Micronutrient Network—SOD2—dilated cardiomyopathy	0.00044	0.00216	CbGpPWpGaD
Repaglinide—SLCO1B1—Transmembrane transport of small molecules—ABCC9—dilated cardiomyopathy	0.000438	0.00215	CbGpPWpGaD
Repaglinide—PPARG—Developmental Biology—PSEN2—dilated cardiomyopathy	0.000429	0.0021	CbGpPWpGaD
Repaglinide—ALB—Response to elevated platelet cytosolic Ca2+—CD36—dilated cardiomyopathy	0.000421	0.00206	CbGpPWpGaD
Repaglinide—ALB—Selenium Micronutrient Network—GPX1—dilated cardiomyopathy	0.00042	0.00206	CbGpPWpGaD
Repaglinide—PPARG—Transcriptional regulation of white adipocyte differentiation—TNF—dilated cardiomyopathy	0.000413	0.00202	CbGpPWpGaD
Repaglinide—CYP2C8—Metabolism of lipids and lipoproteins—ANKRD1—dilated cardiomyopathy	0.000411	0.00201	CbGpPWpGaD
Repaglinide—ALB—Metabolism of lipids and lipoproteins—ANKRD1—dilated cardiomyopathy	0.000409	0.002	CbGpPWpGaD
Repaglinide—PPARG—Metabolism—ANKRD1—dilated cardiomyopathy	0.000405	0.00198	CbGpPWpGaD
Repaglinide—CYP2C8—Metabolism of lipids and lipoproteins—TAZ—dilated cardiomyopathy	0.000386	0.00189	CbGpPWpGaD
Repaglinide—ALB—Metabolism of lipids and lipoproteins—TAZ—dilated cardiomyopathy	0.000384	0.00188	CbGpPWpGaD
Repaglinide—PPARG—Metabolism—TAZ—dilated cardiomyopathy	0.00038	0.00186	CbGpPWpGaD
Repaglinide—PPARG—Gene Expression—NR3C2—dilated cardiomyopathy	0.000361	0.00177	CbGpPWpGaD
Repaglinide—PPARG—Metabolism—SDHA—dilated cardiomyopathy	0.000344	0.00169	CbGpPWpGaD
Repaglinide—ALB—Hemostasis—TTN—dilated cardiomyopathy	0.00032	0.00157	CbGpPWpGaD
Repaglinide—SLCO1B1—Metabolism—ANKRD1—dilated cardiomyopathy	0.000319	0.00156	CbGpPWpGaD
Repaglinide—ABCC8—Neuronal System—RAF1—dilated cardiomyopathy	0.000315	0.00154	CbGpPWpGaD
Repaglinide—KCNJ11—Neuronal System—RAF1—dilated cardiomyopathy	0.000306	0.0015	CbGpPWpGaD
Repaglinide—SLCO1B1—Metabolism—TAZ—dilated cardiomyopathy	0.0003	0.00147	CbGpPWpGaD
Repaglinide—ALB—Hemostasis—ACTN2—dilated cardiomyopathy	0.000277	0.00136	CbGpPWpGaD
Repaglinide—ALB—Transmembrane transport of small molecules—RYR2—dilated cardiomyopathy	0.000277	0.00136	CbGpPWpGaD
Repaglinide—PPARG—Adipogenesis—TNF—dilated cardiomyopathy	0.000272	0.00133	CbGpPWpGaD
Repaglinide—SLCO1B1—Metabolism—SDHA—dilated cardiomyopathy	0.000271	0.00133	CbGpPWpGaD
Repaglinide—ALB—Transmembrane transport of small molecules—SLC22A5—dilated cardiomyopathy	0.000269	0.00132	CbGpPWpGaD
Repaglinide—ALB—Transmembrane transport of small molecules—PLN—dilated cardiomyopathy	0.000269	0.00132	CbGpPWpGaD
Repaglinide—PPARG—Developmental Biology—ITGB1—dilated cardiomyopathy	0.000268	0.00131	CbGpPWpGaD
Repaglinide—ALB—Vitamin B12 Metabolism—TNF—dilated cardiomyopathy	0.000258	0.00127	CbGpPWpGaD
Repaglinide—ALB—Transmembrane transport of small molecules—ABCC9—dilated cardiomyopathy	0.00025	0.00123	CbGpPWpGaD
Repaglinide—ALB—Hemostasis—VCL—dilated cardiomyopathy	0.000236	0.00116	CbGpPWpGaD
Repaglinide—PPARG—Developmental Biology—CD36—dilated cardiomyopathy	0.000229	0.00112	CbGpPWpGaD
Repaglinide—PPARG—Gene Expression—NPPA—dilated cardiomyopathy	0.000226	0.00111	CbGpPWpGaD
Repaglinide—PPARG—Developmental Biology—RAC1—dilated cardiomyopathy	0.000216	0.00106	CbGpPWpGaD
Repaglinide—ALB—Folate Metabolism—TNF—dilated cardiomyopathy	0.00021	0.00103	CbGpPWpGaD
Repaglinide—PPARG—Metabolism of lipids and lipoproteins—GPX1—dilated cardiomyopathy	0.00021	0.00103	CbGpPWpGaD
Repaglinide—PPARG—Metabolism of lipids and lipoproteins—CD36—dilated cardiomyopathy	0.000204	0.001	CbGpPWpGaD
Repaglinide—ALB—Platelet activation, signaling and aggregation—CD36—dilated cardiomyopathy	0.000196	0.00096	CbGpPWpGaD
Repaglinide—ALB—Platelet activation, signaling and aggregation—RAC1—dilated cardiomyopathy	0.000185	0.000904	CbGpPWpGaD
Repaglinide—PPARG—Metabolism of lipids and lipoproteins—AGT—dilated cardiomyopathy	0.000184	0.000901	CbGpPWpGaD
Repaglinide—CYP2C8—Metabolism—ANKRD1—dilated cardiomyopathy	0.000183	0.000897	CbGpPWpGaD
Repaglinide—ALB—Metabolism—ANKRD1—dilated cardiomyopathy	0.000182	0.000892	CbGpPWpGaD
Repaglinide—CYP2C8—Metabolism—TAZ—dilated cardiomyopathy	0.000172	0.000843	CbGpPWpGaD
Repaglinide—ALB—Metabolism—TAZ—dilated cardiomyopathy	0.000171	0.000838	CbGpPWpGaD
Repaglinide—ABCC8—Transmembrane transport of small molecules—RAF1—dilated cardiomyopathy	0.000169	0.00083	CbGpPWpGaD
Repaglinide—ALB—Selenium Micronutrient Network—TNF—dilated cardiomyopathy	0.000167	0.000818	CbGpPWpGaD
Repaglinide—SLCO1B1—Metabolism of lipids and lipoproteins—GPX1—dilated cardiomyopathy	0.000165	0.000809	CbGpPWpGaD
Repaglinide—SLCO1B1—Metabolism of lipids and lipoproteins—CD36—dilated cardiomyopathy	0.000161	0.000788	CbGpPWpGaD
Repaglinide—CYP2C8—Metabolism—SDHA—dilated cardiomyopathy	0.000156	0.000762	CbGpPWpGaD
Repaglinide—ALB—Metabolism—SDHA—dilated cardiomyopathy	0.000155	0.000758	CbGpPWpGaD
Repaglinide—SLCO1B1—Metabolism of lipids and lipoproteins—AGT—dilated cardiomyopathy	0.000145	0.00071	CbGpPWpGaD
Repaglinide—PPARG—Developmental Biology—RAF1—dilated cardiomyopathy	0.000143	0.0007	CbGpPWpGaD
Repaglinide—ABCC8—Metabolism—GPX1—dilated cardiomyopathy	0.00013	0.000639	CbGpPWpGaD
Repaglinide—ABCC8—Metabolism—CD36—dilated cardiomyopathy	0.000127	0.000622	CbGpPWpGaD
Repaglinide—KCNJ11—Metabolism—GPX1—dilated cardiomyopathy	0.000126	0.000619	CbGpPWpGaD
Repaglinide—KCNJ11—Metabolism—CD36—dilated cardiomyopathy	0.000123	0.000603	CbGpPWpGaD
Repaglinide—ALB—Platelet activation, signaling and aggregation—RAF1—dilated cardiomyopathy	0.000122	0.0006	CbGpPWpGaD
Repaglinide—ALB—Hemostasis—ITGB1—dilated cardiomyopathy	0.000118	0.00058	CbGpPWpGaD
Repaglinide—ABCC8—Metabolism—AGT—dilated cardiomyopathy	0.000114	0.00056	CbGpPWpGaD
Repaglinide—KCNJ11—Metabolism—AGT—dilated cardiomyopathy	0.000111	0.000543	CbGpPWpGaD
Repaglinide—ALB—Hemostasis—CD36—dilated cardiomyopathy	0.000101	0.000495	CbGpPWpGaD
Repaglinide—CYP3A4—Metabolism—ANKRD1—dilated cardiomyopathy	9.83e-05	0.000481	CbGpPWpGaD
Repaglinide—PPARG—Developmental Biology—EGFR—dilated cardiomyopathy	9.8e-05	0.00048	CbGpPWpGaD
Repaglinide—SLCO1B1—Transmembrane transport of small molecules—RAF1—dilated cardiomyopathy	9.56e-05	0.000468	CbGpPWpGaD
Repaglinide—ALB—Hemostasis—RAC1—dilated cardiomyopathy	9.52e-05	0.000466	CbGpPWpGaD
Repaglinide—CYP2C8—Metabolism of lipids and lipoproteins—GPX1—dilated cardiomyopathy	9.49e-05	0.000465	CbGpPWpGaD
Repaglinide—ALB—Metabolism of lipids and lipoproteins—GPX1—dilated cardiomyopathy	9.44e-05	0.000462	CbGpPWpGaD
Repaglinide—PPARG—Metabolism—GPX1—dilated cardiomyopathy	9.34e-05	0.000458	CbGpPWpGaD
Repaglinide—PPARG—Developmental Biology—TNF—dilated cardiomyopathy	9.34e-05	0.000457	CbGpPWpGaD
Repaglinide—CYP2C8—Metabolism of lipids and lipoproteins—CD36—dilated cardiomyopathy	9.25e-05	0.000453	CbGpPWpGaD
Repaglinide—CYP3A4—Metabolism—TAZ—dilated cardiomyopathy	9.24e-05	0.000453	CbGpPWpGaD
Repaglinide—ALB—Metabolism of lipids and lipoproteins—CD36—dilated cardiomyopathy	9.19e-05	0.00045	CbGpPWpGaD
Repaglinide—PPARG—Metabolism—CD36—dilated cardiomyopathy	9.1e-05	0.000446	CbGpPWpGaD
Repaglinide—CYP3A4—Metabolism—SDHA—dilated cardiomyopathy	8.35e-05	0.000409	CbGpPWpGaD
Repaglinide—CYP2C8—Metabolism of lipids and lipoproteins—AGT—dilated cardiomyopathy	8.32e-05	0.000408	CbGpPWpGaD
Repaglinide—ALB—Metabolism of lipids and lipoproteins—AGT—dilated cardiomyopathy	8.28e-05	0.000405	CbGpPWpGaD
Repaglinide—PPARG—Metabolism—AGT—dilated cardiomyopathy	8.19e-05	0.000401	CbGpPWpGaD
Repaglinide—SLCO1B1—Metabolism—GPX1—dilated cardiomyopathy	7.36e-05	0.00036	CbGpPWpGaD
Repaglinide—SLCO1B1—Metabolism—CD36—dilated cardiomyopathy	7.17e-05	0.000351	CbGpPWpGaD
Repaglinide—SLCO1B1—Metabolism—AGT—dilated cardiomyopathy	6.45e-05	0.000316	CbGpPWpGaD
Repaglinide—ALB—Hemostasis—RAF1—dilated cardiomyopathy	6.31e-05	0.000309	CbGpPWpGaD
Repaglinide—ALB—Transmembrane transport of small molecules—RAF1—dilated cardiomyopathy	5.46e-05	0.000268	CbGpPWpGaD
Repaglinide—CYP2C8—Metabolism—GPX1—dilated cardiomyopathy	4.23e-05	0.000207	CbGpPWpGaD
Repaglinide—ALB—Metabolism—GPX1—dilated cardiomyopathy	4.2e-05	0.000206	CbGpPWpGaD
Repaglinide—CYP2C8—Metabolism—CD36—dilated cardiomyopathy	4.12e-05	0.000202	CbGpPWpGaD
Repaglinide—ALB—Metabolism—CD36—dilated cardiomyopathy	4.09e-05	0.000201	CbGpPWpGaD
Repaglinide—CYP2C8—Metabolism—AGT—dilated cardiomyopathy	3.71e-05	0.000182	CbGpPWpGaD
Repaglinide—ALB—Metabolism—AGT—dilated cardiomyopathy	3.69e-05	0.000181	CbGpPWpGaD
Repaglinide—CYP3A4—Metabolism—GPX1—dilated cardiomyopathy	2.27e-05	0.000111	CbGpPWpGaD
Repaglinide—CYP3A4—Metabolism—CD36—dilated cardiomyopathy	2.21e-05	0.000108	CbGpPWpGaD
Repaglinide—CYP3A4—Metabolism—AGT—dilated cardiomyopathy	1.99e-05	9.75e-05	CbGpPWpGaD
